Lv3
240 积分 2022-05-11 加入
Safety and pharmacokinetic evaluation of repeated intravenous administration of palonosetron 0.75 mg in patients receiving highly or moderately emetogenic chemotherapy
21天前
已完结
Advanced detection, personalized treatment and equitable care: welcome to the future of oncology
23天前
已完结
Advanced detection, personalized treatment and equitable care: welcome to the future of oncology
23天前
已关闭
Netupitant plus palonosetron is a cost-effective treatment for the prophylaxis of chemotherapy-induced nausea and vomiting in highly and moderately emetogenic cancer treatment
25天前
已完结
Autophagy inhibition enhances PD-1 blockade efficacy in mismatch repair–proficient colorectal cancer
3个月前
已关闭
EGFR-RAD51 fusion in lung adenocarcinoma with systemic and intracranial response to osimertinib: A case report and review of the literature
5个月前
已完结
Survival After Fertility-Preserving Hormonal Therapy vs Hysterectomy for Early-Stage Endometrial Cancer
6个月前
已完结
Comparison of oncologic outcomes between completion hysterectomy and no completion hysterectomy in patients who achieved complete response and completed childbearing after fertility-sparing treatment for early-stage endometrial cancer: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3001)
6个月前
已关闭
Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
7个月前
已完结
Impact of EGFR exon 19 deletion subtypes on clinical outcomes in EGFR-TKI-Treated advanced non-small-cell lung cancer
8个月前
已完结
皖公网安备34019202002308
